Canada markets closed

Gene Biotherapeutics, Inc. (CRXM)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 11:03AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
Total Revenue
0
0
0
Operating Expenses
Research Development
217.582
217.582
243.453
Selling General and Administrative
1,045
1,045
593.549
Total Operating Expenses
1,262
1,262
837.002
Operating Income or Loss
-1,262
-1,262
-837.002
Interest Expense
57.4
57.4
43.787
Total Other Income/Expenses Net
-173.555
668.032
1,660
Income Before Tax
-651.55
-651.55
779.128
Income from Continuing Operations
-651.55
-651.55
779.128
Net Income
-517.897
-517.897
866.675
Net Income available to common shareholders
-517.897
-517.897
866.675
Basic EPS
-0.02
-
0.05
Diluted EPS
-0.02
-
0.05
Basic Average Shares
24,116
-
14,486
Diluted Average Shares
24,116
-
14,486